Delivery Order SPE2DR25D2104-SPE2DR26F3PHP
- Not listed
- The Defense Logistics Agency awarded a $459 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for the supply of 28 tablets of estradiol-norethindrone 1-0.5 mg. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill DLA requirements. No subcontractors or additional context were provided regarding the delivery order. The single delivery order was awarded on July 26,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Norethindrone-Ethinyl Estradiol 0.5-2.5mg tablets (28-count package), with a contract ceiling value of $1,232.93. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract is scheduled for completion by September 17, 2025, with performance to occur at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,192.88 to AmerisourceBergen Drug Corp for the supply of Estradiol 10 mcg vaginal inserts (8-count packages) under a firm fixed-price contract. The award was made on September 26, 2025, with an ultimate completion date of September 29, 2025, and is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $54,360 to Amerisourcebergen Drug Corporation to supply 100 boxes of 1 mg estradiol tablets. The order is being fulfilled under Amerisourcebergen's Prime Vendor Program contract with DLA for pharmaceutical products. Performance will occur at Amerisourcebergen's distribution facility in Conshohocken, Pennsylvania, with delivery required between August 22nd and 23rd, 2023. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a delivery order valued at $1,072.08 to AmerisourceBergen Drug Corp for the supply of Estradiol 0.01% cream in 42.5-gram quantities. This firm fixed-price delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Estradiol 0.01% cream in 42.5 gram units, with a ceiling value of $3,720.99 and an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $123,760 delivery order to Amerisourcebergen Drug Corporation for the supply of 2 mg estradiol tablets. The firm fixed price order is for 100 count packages of the pharmaceutical product and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by June 27, 2023 in support of DLA's medical supply needs. No subcontractors or set aside designations were identified. The order was issued under an existing DLA pharmaceutical supply...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $368 to Amerisourcebergen Drug Corporation for the supply of 2 mg estradiol tablets. As the prime contractor, Amerisourcebergen will deliver 100 count bottles of the pharmaceutical product to a facility in Conshohocken, Pennsylvania between July 7-10, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency functions to provide logistics support to the Department...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Estradiol 0.01% Cream (42.5GM) on September 19, 2025, with a ceiling value of $1,114.92 and an ultimate completion date of September 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $18,120 to Amerisourcebergen Drug Corporation for the supply of 100 estradiol 1 mg tablets. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania under a period of performance spanning August 9-10, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency functions to provide logistics support to the...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3PHPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,275.15 to AmerisourceBergen Drug Corp for Estradiol-Norethindrone 0.5-0.1 mg tablets (28-count unit dose packaging). This is a firm fixed price, non-set-aside contract awarded on November 18, 2025, with an ultimate completion date of November 19, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical prime vendor agreement running through December 2026 that supplies critical medications and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company was competitively selected for this delivery order, consistent with its demonstrated capability to fulfill federal medical procurement requirements across multiple therapeutic domains, including hormone treatments, specialty medications, and medical supplies. As a prime contractor on the DLA's comprehensive pharmaceutical supply vehicle, AmerisourceBergen maintains extensive capacity to deliver brand-name and generic medications supporting military medical operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/18/25 |